Yuhui Sun | Gene Therapy | Excellence in Research

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications

Zafran Khan | Tuberculosis Researcher | Editorial Board Member

Mr. Zafran Khan | Tuberculosis | Editorial Board Member

University of Calgary | Pakisthan

Author Profile

Google Scholar

Orcid ID

EARLY ACADEMIC PURSUITS:

ZAFRAN KHAN initiated his academic journey at the University of Swat (UOS) in Swat, Pakistan, where he pursued a Bachelor of Science (Hons) in Microbiology from 2012 to 2016. During this period, he conducted research on the "Incidence of HCV in the general population of District Swat, Pakistan," showcasing an early interest in infectious diseases and molecular biology.

PROFESSIONAL ENDEAVORS:

Following his undergraduate studies, ZAFRAN KHAN ventured into higher education at the University of Chinese Academy of Sciences (UCAS) in Beijing, China. Here, he enrolled as a Master student in Biochemistry and Molecular Biology from September 2018 to August 2019. His coursework covered diverse topics, including Genomics, Immunology, Biochemistry, and Molecular Biology, laying a solid foundation for his subsequent research pursuits.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUBERCULOSIS

ZAFRAN KHAN's notable research contributions are evident during his tenure as a Master's Full-time Research Candidate at the State Key Laboratory of Respiratory Infectious Disease (GIBH) in Guangzhou, China, from August 2019 to August 2021. His primary research focus encompassed Mycobacterium tuberculosis resistance mechanisms, novel drug targets, docking, molecular dynamic simulation, and vaccine and drug designing. Noteworthy projects include the identification of resistance mechanisms associated with prothionamide and amikacin in Mycobacterium tuberculosis clinical isolates.

IMPACT AND INFLUENCE:

ZAFRAN KHAN's work holds significant implications for understanding and combating tuberculosis, a global health concern. His efforts in exploring unexplored resistance mechanisms and conducting molecular detection of anti-tubercular resistance in clinical isolates contribute to the broader scientific community's knowledge base. The impact of his research extends beyond borders, as evidenced by his involvement in international conferences and workshops.

ACADEMIC CITES:

ZAFRAN KHAN's academic journey is marked by a commitment to excellence, exemplified by his active participation in international conferences and workshops. This exposure has likely contributed to his knowledge enrichment and the incorporation of global perspectives into his research.

LEGACY AND FUTURE CONTRIBUTIONS:

ZAFRAN KHAN has established a legacy of dedication and proficiency in the field of Microbiology and Molecular Biology. His early research on HCV in Swat and subsequent work on tuberculosis resistance mechanisms showcase a commitment to addressing critical health challenges. As he progresses in his academic and research journey, ZAFRAN KHAN is poised to make further contributions to the scientific community, leaving a lasting legacy in the realm of infectious diseases and immunity.

Notable Publications

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?  2022(9)

Cold stress-induced seed germination and biosynthesis of polyphenolics content in medicinally important Brassica rapa 2022(8)

Chimeric antigen receptor T cell structure, its manufacturing, and related toxicities; a comprehensive review 2022(7)